(Q37883517)

24 August 2017

1 reference

title

The clinical pharmacokinetics of levofloxacin (English)

1 reference

24 August 2017

1 reference

Fish DN

1

1 reference

24 August 2017

Chow AT

series ordinal

2

1 reference

24 August 2017

language of work or name

1 reference

1 February 1997

1 reference

Clinical Pharmacokinetics

24 August 2017

published in

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

101-119

1 reference

Pharmacokinetics of three newer quinolones in pregnant and lactating women

24 August 2017

cites work

1 reference

12 December 2020

Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid

1 reference

12 December 2020

[Laboratory and clinical studies on levofloxacin].

1 reference

12 December 2020

Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity

1 reference

12 December 2020

Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections

1 reference

12 December 2020

Comparative penetration of lomefloxacin and other quinolones into human phagocytes

1 reference

12 December 2020

Enantioselective disposition of ofloxacin in humans

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

1 reference

12 December 2020

Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine

1 reference

12 December 2020

Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes

1 reference

12 December 2020

Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.

1 reference

12 December 2020

Enoxacin--a potent inhibitor of theophylline metabolism.

1 reference

12 December 2020

A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients

1 reference

12 December 2020

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

1 reference

12 December 2020

Inhibition of DNA gyrase by optically active ofloxacin

1 reference

12 December 2020

Clinical relevance of intracellular and extracellular concentrations of macrolides

1 reference

12 December 2020

[Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections]

1 reference

12 December 2020

Acute nongonococcal epididymitis--pharmacological and therapeutic aspects of levofloxacin

1 reference

12 December 2020

Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones

1 reference

12 December 2020

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Fundamental study on levofloxacin in the field of obstetrics and gynecology

1 reference

12 December 2020

The mode of action of 4-quinolones and possible mechanisms of resistance

1 reference

12 December 2020

Clinical pharmacology and efficacy of levofloxacin in elderly patients

1 reference

12 December 2020

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

12 December 2020

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

1 reference

12 December 2020

Quinolone antimicrobial agents and theophylline

1 reference

12 December 2020

Quantification of the enantiomers of ofloxacin in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

The effect of levofloxacin, an optically-active isomer of ofloxacin, on fecal microflora in human volunteers

1 reference

12 December 2020

Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans

1 reference

12 December 2020

Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils

1 reference

12 December 2020

Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management

1 reference

12 December 2020

Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells

1 reference

12 December 2020

Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.

1 reference

12 December 2020

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

1 reference

12 December 2020

Synthesis and antibacterial activities of optically active ofloxacin

1 reference

12 December 2020

Biotransformation of selected gyrase inhibitors

1 reference

12 December 2020

Pharmacokinetics of ofloxacin after parenteral and oral administration

1 reference

12 December 2020

Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide

1 reference

12 December 2020

Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy

1 reference

12 December 2020

10.2165/00003088-199732020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1000446062

0 references

1 reference